Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...
The Food and Drug Administration approved Adamas Pharmaceuticals’ drug Gocovri to treat dyskinesia, a side effect of a medication prescribed to most Parkinson’s disease patients, reports Reuters. Here ...
University of Iowa researchers identified a connection between a routine treatment for Parkinson’s disease and a tendency for some patients to develop increased impulsivity located around a specific ...
Hosted on MSN
New weekly injectable drug could transform the lives of people living with Parkinson’s disease
A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with this condition worldwide, daily treatment has meant taking levodopa and ...
There are 18,000 people diagnosed with Parkinson's in the UK each year and following their diagnosis, most will be started on a series of treatments to slow the effects of the disease, which damages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback